Erin Sebal
Summary
Respected commercial leader with diverse experience, established credibility and a passion for our mission to save and improve lives. Demonstrated track record of personal achievement, earning successive promotions into roles of increasing responsibility. Sustained record of meaningful contributions across a broad range of therapeutic areas, across domestic and international markets and across various teams. Innately curious and constantly seeking new challenges.
Overview
5
5
years of professional experience
Work History
US Pharma New Products Marketing
Merck & Co., Inc
02.2022 - Current
- Responsible for assets being considered for launch in the US Market in both the US Pharma and Rare Disease business units. Inclusive of early stage pipeline products and evaluation of potential targets for business development activities.
- Assess new products in the context of the US Market. Understand the relevant market, required value proposition for all target customer segments and providing long-term forecasting.
- Collaboration across broad set of internal stakeholders to ensure accurate feedback to Global and BD.
- Lead a team of 3 direct reports, including objective setting, routine feedback, coaching, career development planning and annual performance assessments.
MARKETING DIRECTOR
Merck & Co., Inc
01.2019 - 01.2022
- Provided strategic direction of the $5B sitagliptin franchise, largest revenue generator in Global Pharma and third largest company-wide
- Broad cross-functional responsibilities include late-life cycle and LOE Strategy, commercial representative on Product Development Team (PDT), GS&OP Lead, member of Product Surveillance Team (PST)
- Review and approve Product Expansion Authorization (PEA) and Price Action Review Form (PARF)
- Led and evolve Diabetes GCT ways of working, focusing on key priorities and measurably improving accountability and productivity
- Led first L3 roll-out for a Global Franchise
Education
Women's Leadership Program -
Cornell University
01.2021
Behavioral Economics: Understanding and Shaping Customer Behavior -
Harvard Business School
01.2016
Principles of Pharma Marketing Research Certification Course -
Univ of Georgia
01.2013
Master of Science in Biology -
Duquesne Univ
01.1996
Bachelor of Science in Biology -
St. Mary's College
Notre Dame, IN01.1993
Skills
- Data-driven decision-making
- People Management
- Global and US Marketing
- Customer Insights
- Behavioral Science
- Pharmaceutical Sales
- Stakeholder Management
- Strategic Planning
- Brand strategy
- Pricing strategy
- Product Lifecycle Management
- Team building
Accomplishments
- Ways of Working Award| 2020
- Catalyst for change and exemplar of embracing new Ways of Working
- DAVID OGILVY AWARD
- ARF/New York | 2016 & 2017
- Honors achievements in insights that lead to successful advertising
- MRL TEAM COLLABORATION
- Merck | 2015
- Insulin receptor partial agonist development program
- LAUNCH EXCELLENCE
- Merck | 2013
- Recognize excellence in launch planning and execution
- VP PREMIER AWARD
- Merck | 2007
- Top 5% in sales
References
- MIKE MEEHAN, MERCK, AVP, GLOBAL MARKETING, michael.meehan@merck.com, (267) 305-0457
- BRIAN WOOLHOUSE, MERCK, VP, GLOBAL MARKETING, brian.woolhouse@merck.com, (908) 740-5090
- PAMELA ROOTKIE, MERCK, EXEC DIRECTOR MARKETING, US VACCINES, pamela_rootkie@merck.com, (267) 305-5890
- KEITH KAUFMAN, MERCK, VP, CLINICAL RESEARCH, keith_kaufman@merck.com, (732) 594-5821
Hobbies and Interests
- Behavioral Science
- Founding member of BEAM (Behavioral Economics at Merck)
Timeline
US Pharma New Products Marketing
Merck & Co., Inc
02.2022 - Current
MARKETING DIRECTOR
Merck & Co., Inc
01.2019 - 01.2022
Women's Leadership Program -
Cornell University
Behavioral Economics: Understanding and Shaping Customer Behavior -
Harvard Business School
Principles of Pharma Marketing Research Certification Course -
Univ of Georgia
Master of Science in Biology -
Duquesne Univ
Bachelor of Science in Biology -
St. Mary's College